June 12, 2020-June 18, 2020 The Rare Disease Clinical Outcome Assessment Consortium: Aiming to Fulfill Unmet Drug Development Endpoint Measurement Needs Presented at the DIA Virtual Global Annual Meeting, held June 12 – 18, 2020.
May 6, 2020 Webinar: What you want and need to know about the Rare Disease Cures Accelerator – Data and Analytics Platform (May 6, 2020)
April 27, 2020 Critical Path for Parkinson’s Consortium 3DT Initiative: Early regulatory engagement to optimize paths for efficient use of digital health technologies in PD clinical trials A subset of CPP member organizations* have convened to collaborate precompetitively with the goal of optimizing the efficiency of
October 21, 2019 Towards EMA Qualification of Islet Auto-Antibodies as a Model-Based Clinical Trial Enrichment Platform for Type-1 Diabetes Prevention Studies
September 23, 2019 Enabling efficient use of digital health technologies to support Parkinson’s disease drug development through precompetitive collaboration
